Youth-led climate groups are getting a $25 million injection from a funding collaborative. Enlight Foundation President Xin ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

As India becomes the new and latest nation witnessing the for weight-loss drugs frenzy, Novo Nordisk’s Wegovy challenges Eli ...

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released ...

Eli Lilly (NYSE: LLY) recently ... laying a foundation for future growth. Over the past five years, Eli Lilly has delivered a very large total return of 431%, reflecting its robust performance.

Former Eli Lilly CEOs donate $20 million to fund new institute at IU Health. ... Enroll 300,000 patients in the Indiana Biobank initiative over the next five years to serve as the foundation for ...